R. Mairs

1.1k total citations
47 papers, 852 citations indexed

About

R. Mairs is a scholar working on Neurology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, R. Mairs has authored 47 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Neurology, 18 papers in Cancer Research and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in R. Mairs's work include Neuroblastoma Research and Treatments (21 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Glioma Diagnosis and Treatment (11 papers). R. Mairs is often cited by papers focused on Neuroblastoma Research and Treatments (21 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Glioma Diagnosis and Treatment (11 papers). R. Mairs collaborates with scholars based in United Kingdom, United States and Australia. R. Mairs's co-authors include Mark N. Gaze, Marie Boyd, T. E. Wheldon, A. Livingstone, A. John Barrett, Mary M. Brown, Michael R. Zalutsky, M.M. Ferguson, Ganesan Vaidyanathan and R Rampling and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Biochemical Pharmacology.

In The Last Decade

R. Mairs

46 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Mairs United Kingdom 19 336 274 219 189 173 47 852
P. Markus Deckert Germany 16 115 0.3× 72 0.3× 323 1.5× 135 0.7× 163 0.9× 44 838
Jennifer Fischbach United States 8 113 0.3× 88 0.3× 103 0.5× 235 1.2× 340 2.0× 12 890
Óscar Gallego Spain 19 73 0.2× 178 0.6× 282 1.3× 83 0.4× 266 1.5× 68 1.3k
C. B. Wilson United States 13 297 0.9× 68 0.2× 125 0.6× 95 0.5× 68 0.4× 22 622
Maury Rosenstein United States 17 35 0.1× 80 0.3× 232 1.1× 200 1.1× 194 1.1× 35 1.4k
Andrea Lamprecht Austria 9 146 0.4× 160 0.6× 294 1.3× 16 0.1× 90 0.5× 14 1.1k
E. van der Schueren Belgium 16 28 0.1× 83 0.3× 77 0.4× 228 1.2× 217 1.3× 48 716
Eugenie Kleinerman United States 15 41 0.1× 112 0.4× 369 1.7× 55 0.3× 176 1.0× 24 783
Stanley Frankel United States 13 73 0.2× 74 0.3× 514 2.3× 97 0.5× 101 0.6× 24 1.2k
Andras Heczey United States 19 267 0.8× 149 0.5× 527 2.4× 34 0.2× 82 0.5× 49 2.1k

Countries citing papers authored by R. Mairs

Since Specialization
Citations

This map shows the geographic impact of R. Mairs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Mairs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Mairs more than expected).

Fields of papers citing papers by R. Mairs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Mairs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Mairs. The network helps show where R. Mairs may publish in the future.

Co-authorship network of co-authors of R. Mairs

This figure shows the co-authorship network connecting the top 25 collaborators of R. Mairs. A scholar is included among the top collaborators of R. Mairs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Mairs. R. Mairs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCarthy, Helen O., Jenny Worthington, Emilio Cosimo, et al.. (2006). p21(WAF1)-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy. Gene Therapy. 14(3). 246–255. 39 indexed citations
2.
Boyd, Marie, Sarajane Ross, Sally L. Pimlott, et al.. (2005). Comparison of Radiohaloanalogues of Meta-Iodobenzylguanidine (MIBG) for a Combined Gene- and Targeted Radiotherapy Approach to Bladder Carcinoma. Medicinal Chemistry. 1(6). 611–618. 7 indexed citations
3.
Boyd, Marie, et al.. (2004). A sensitive and reproducible method for identification of radiation-induced mutations: Implications for radiation treatment &AN&protection. British Journal of Cancer. 91. 1 indexed citations
4.
Boyd, Marie, R. Mairs, W. Nicol Keith, et al.. (2004). Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate. Prostate Cancer and Prostatic Diseases. 7(4). 355–363. 10 indexed citations
5.
Boyd, Marie, et al.. (2002). Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy. The Journal of Gene Medicine. 4(5). 567–576. 32 indexed citations
6.
Mairs, R., et al.. (2000). Applications of Gene Transfer to Targeted Radiotherapy. Current Pharmaceutical Design. 6(14). 1419–1432. 11 indexed citations
7.
8.
Boyd, Marie, et al.. (1999). Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine. Gene Therapy. 6(6). 1147–1152. 51 indexed citations
9.
10.
Mairs, R., et al.. (1998). Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions. British Journal of Cancer. 77(12). 2061–2068. 41 indexed citations
11.
Armour, Alexis, et al.. (1997). The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro. British Journal of Cancer. 75(4). 470–476. 32 indexed citations
12.
Neshasteh‐Riz, Ali, et al.. (1997). INCORPORATION OF IODODEOXYURIDINE IN MULTICELLULAR GLIOMA SPHEROIDS: ELECTRON EMITTERS. 75(4). 493–499. 1 indexed citations
13.
Armour, Alexis, et al.. (1994). Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature. British Journal of Cancer. 70(3). 445–448. 6 indexed citations
14.
Livingstone, A., R. Mairs, James Russell, et al.. (1994). N-myc gene copy number in neuroblastoma cell lines and resistance to experimental treatment. European Journal of Cancer. 30(3). 382–389. 16 indexed citations
15.
Mairs, R., A. Livingstone, Mark N. Gaze, T. E. Wheldon, & A. John Barrett. (1994). Prediction of accumulation of 131I-labelled meta-iodobenzylguanidine in neuroblastoma cell lines by means of reverse transcription and polymerase chain reaction. British Journal of Cancer. 70(1). 97–101. 38 indexed citations
16.
Gaze, Mark N., et al.. (1992). 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes. British Journal of Cancer. 66(6). 1048–1052. 48 indexed citations
17.
Mairs, R., Mark N. Gaze, & A. John Barrett. (1991). The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G. British Journal of Cancer. 64(2). 293–295. 28 indexed citations
18.
Gaze, Mark N., et al.. (1991). Intracellular localization of metaiodobenzyl guanidine in human neuroblastoma cells by electron spectroscopic imaging. International Journal of Cancer. 47(6). 875–880. 32 indexed citations
19.
Mairs, R. & J.A. Beeley. (1987). Isoelectric focusing of human salivary secretory-IgA. Archives of Oral Biology. 32(12). 873–877. 4 indexed citations
20.
Ferguson, M.M., et al.. (1984). Are antithyroid drugs immunosuppressive?. BMJ. 288(6422). 1004.2–1005. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Markus Deckert Breakdown of academic impact, for papers by Jennifer Fischbach Breakdown of academic impact, for papers by Óscar Gallego Breakdown of academic impact, for papers by C. B. Wilson Breakdown of academic impact, for papers by Maury Rosenstein Breakdown of academic impact, for papers by Andrea Lamprecht Breakdown of academic impact, for papers by E. van der Schueren Breakdown of academic impact, for papers by Eugenie Kleinerman Breakdown of academic impact, for papers by Stanley Frankel Breakdown of academic impact, for papers by Andras Heczey
Rankless by CCL
2026